WELCOME TO GROUP OTONKOSKI’S PAGES

Otonkoski lab is interested in nuclear reprogramming and genome editing, and how these can be applied to understand mechanisms behind pancreatic beta-cell failure leading to diabetes. We also operate a Core Facility service, the Biomedicum Stem Cell Centre (BSCC).
Read more

Research highlights

@OtonkoskiL

#stemcells derived islet transplantation is a promising treatment for #diabetes. How do #SC-islets compare to prima… twitter.com/i/web/status/1…

Up front & free to read in our March issue #editorspicks: Model of #congenitalhyperinsulinism based on patient stem… twitter.com/i/web/status/1…